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ABSTRACT 
Objective: To investigate the antimicrobial and cytotoxic activities of bioactive compounds produced by Streptomyces sp. KB1 isolated from the air 
sample at Ao-nang, Krabi province, Thailand. 
Methods: Streptomyces sp. KB1 was identified by 16S rDNA gene sequencing. It was preliminarily investigated the antibacterial activity by cross 
streak method and then cultivated in the half-formula of Luria Bertani at 30 °C, 200 rpm in shaking incubator for 7 d. Culture broth of each day was 
prepared as cell-free culture broth and tested the anti-Staphylococcus aureus TISTR 517 activity by agar well diffusion method along with 
determined the protein concentration by Bradford assay. Bioactive compounds were assessed the antimicrobial activity and cytotoxicity against 
brine shrimp by broth microdilution method and brine shrimp lethality bioassay, respectively. 
Results: Bioactive compounds were excreted into liquid culture medium within 2 d of cultivation and showed a broad spectrum of antibacterial 
activity. Whereas, the highest activity has shown since day 4th of an incubation period which had protein concentration equal 254 ± 3.1 µg/ml. 
Bioactive compounds showed strong activity against Gram-positive bacteria, moderate activity against Gram-negative bacteria and weak activity 
against yeasts and Pseudomonas aeruginosa TISTR 1467. The MIC, MBC or MFC, and LC50
Conclusion: This study implied that bioactive compounds produced by Streptomyces sp. KB1 may be the important polypeptide compound that can 
be used as lead compounds for novel drug discovery.  
 value of bioactive compounds were in the range of 0.49-
63.50, 0.49-127.00, and 131.58 µg/ml, respectively. 
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INTRODUCTION 
Currently, bioactive compounds have been studied worldwide due to 
they could be used as a model for development of novel or important 
medical agents [1]. With the discovery of bioactive compounds, one 
important source is microorganism especially terrestrial bacteria in 
the order actinomycetes [2]. Actinomycetes are Gram-positive 
bacteria that are widespread in nature. Among order actinomycetes, 
the members of the genus Streptomyces, is in the family 
Streptomycetaceae, are considered as important bioactive 
compounds producer because about 80% of total bioactive 
compounds that are used to develop as antibiotics, antifungal-, 
antitumoral-, antihelminthic-, antiviral-, immunomodulators-agents, 
herbicides and insecticides are produced by this genus [3, 4]. 
Streptomyces are chemoorganotrophic, non-fastidious, filamentous 
and aerobic bacteria, spore forming and non-motile with high G+C 
content (approximately 69-78%) in their DNA. They are free-living, 
saprophytic bacteria, widely distributed in soil, water and colonizing 
plants. In inappropriate environment, most Streptomyces usually 
produced secondary metabolites to kill or inhibit the growth of the 
related microorganisms [5]. Therefore, most of secondary 
metabolites were generally secreted outside the cell which often 
occurred at the late growth phase. Secondary metabolites that have 
such biological property were called as bioactive compounds. The 
temporal nature of bioactive compounds was controlled to 
synthesize by genetic biosynthesis, which was greatly connected 
with primary metabolism and influenced by environmental 
manipulation. Bioactive compounds, products of secondary 
metabolism, are low molecular (MW<3000 Da), chemically and 
taxonomically extremely diverse compounds which are not essential 
for normal growth, development or reproduction. From several 
medical problems, especially the old antibiotic resistance of 
pathogenic and/or opportunistic bacteria was continuously 
increasing [6]. As a result, the bioactive compounds were intensively 
studied to be possible for the development of new antibiotics [7]. 
Whereas, many bioactive compounds should not to develop as new 
antibiotic because it has cytotoxic activity, etc. Therefore, this study 
aims to investigate the antimicrobial and cytotoxic activities of 
bioactive compounds from Streptomyces sp. KB1 for possible 
evaluation that these bioactive compounds should be studied further 
in the future.  
MATERIALS AND METHODS 
Microorganisms, Media and cultural conditions  
Producing strain: Streptomyces sp. KB1 was collected from the air 
sample at Ao-nang, Krabi province, Thailand, by using Biosampler, 
Microflow 90 (Aquaria, Italy), at flow rate 100 l/min for 30 min 
according to the manufacture’s instruction and isolated as pure 
culture on a half-formula of Luria Bertani (LB/2; Himedia, India) 
agar medium (5 g/l Tryptone, 2.5 g/l Yeast extract, 5 g/l NaCl and 
15 g/l Agar powder). The isolate was identified by means of 16S 
rDNA gene sequence analysis at the National Center for Genetic 
Engineering and Biotechnology (BIOTEC), Pathum Thani province, 
Thailand, and published in the Gen Bank database (NCBI, USA). 
Later, it was cultured on LB/2 agar medium at 30 °C in static 
incubator (WTB binder, Germany) for 5 d. Single colony was 
inoculated into 10 ml of LB/2 broth medium in 25 × 150 mm of the 
screw cap test tube, incubated at 30 °C, 200 revolution per minute 
(rpm) in shaking incubator (Thermo scientific, USA) for 2 d or 
until the cells grown up to late logarithmic phase and stored in 15 
% glycerol at-80 °C until use. 
Indicator microorganisms: A total of 9 indicator microorganisms 
include representatives of Gram-positive bacteria viz. Bacillus cereus 
TISTR 11778, Micrococcus luteus TISTR 884 and Staphylococcus 
aureus TISTR 517, Gram-negative bacteria viz. Escherichia coli TISTR 
887, Extended-spectrum Beta-lactamases (ESBL) in a clinical isolate 
of E. coli, Pseudomonas aeruginosa TISTR 1467 and Salmonella 
typhimurium TISTR 292 and yeasts viz. Candida albicans and 
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Cryptococcus neoformans. Both representatives of Gram-positive and 
Gram-negative bacteria were cultured in LB agar medium at 37 °C in 
static incubator for 24 h. A single colony of each isolate was 
inoculated into 10 ml of LB broth medium in 25 × 150 mm of the 
screw cap test tube, incubated at 37 °C, 200 rpm in shaking 
incubator for 24 h. While, yeasts were cultured in Sabouraud 
Dextrose (SD) agar medium at 30 °C in static incubator for 48 h. 
After incubation, single colony of each representative of yeast was 
inoculated into 10 ml of SD broth medium in 25 × 150 mm of the 
screw cap test tube, incubated at 30 °C, 200 rpm in shaking 
incubator for 48 h. The cell of each indicator microorganism was 
stored in 15 % glycerol at-80 °C until use. 
Antibacterial activity screening 
Efficiency of bioactive compounds, produced by Streptomyces sp. 
KB1, was preliminarily investigated against indicator bacteria 
include B. cereus TISTR 11778, M. luteus TISTR 884, S. aureus TISTR 
517, ESBL in a clinical isolate of E. coli, Ps. aeruginosa TISTR 1467 
and S. typhimurium TISTR 292 by cross streak method [8]. Briefly, 
Streptomyces sp. KB1 was streaked as a line at the central position of 
the LB/2 agar plate about 0.6 × 7.5 cm and assigned as experimental 
plate. While, the unstreaked LB/2 agar plate was assigned as control 
plate. Both experimental and control plates were incubated at 30 °C 
in static incubator for 7 d.  
After incubation, loopful of each freshly prepared indicator 
microorganism, adjusted turbidity with sterile normal saline 
solution equal to McFarland No. 0.5, was streaked on both 
experimental and control plates in the manner of perpendicular with 
the central line of Streptomyces sp. KB1 and then again incubated at 
37 °C in static incubator for 24 h. The preliminary antibacterial 
activity was investigated by comparing the length of growth line of 
indicator bacteria between experimental and control plate.  
Phylogenetic analysis 
Almost complete sequence (1,445 bp) of the 16S rDNA gene was 
determined and compared with those of other closely related taxa 
retrieved from the Gen Bank database. Phylogenetic tree was 
constructed by the neighbor-Joining plot. A sequence similarity 
search was done using Gen Bank BLASTN (www. ncbi. nlm. nih. 
gov/blst). Sequences of closely related taxes were retrieved and 
aligned by means of the MEGA 4 program. For the neighbor-joining 
analysis, the distances between sequences were calculated using 
Kimura's two-parameter model. Bootstrap analysis was done to 
evaluate the confidence limits of the branching. 
Cultivation of producing strain and preparation of cell-free 
culture broth  
1 × 1 cm2
Minimum inhibitory concentration (MIC) assay 
 of initial streak of 5 d culture of Streptomyces sp. KB1 was 
inoculated to 25 × 150 mm screw cap test tube containing 10 ml of 
LB/2 broth medium. Inoculum was incubated at 30 °C, 200 rpm in 
the shaking incubator for 7 d. Every day, 100 µl of culture broth was 
harvested and centrifuged to separate the bacterial cell sediment at 
4 °C, 12,000 rpm for 20 min. The supernatant was harvested and 
filtered through a 0.2 µm pore-size filter (Millipore, Germany) to 
remove residual bacterial cells by using aseptic technique. The 
received product was called as cell-free culture broth. Afterward, the 
cell-free culture broth was assessed anti-S. aureus TISTR 517 activity 
by agar well diffusion method [9] and measured the protein 
concentration by Bradford assay [10]. 
MIC value was determined by means of broth microdilution method 
[11]. The cell-free culture broth that showed significant highest anti-
S. aureus TISTR 517 activity was diluted as 2-fold serial by Muller 
Hinton (MH) broth medium for indicator bacteria and SD broth 
medium for yeast in 96 well plates. The wells which contained 100 
µl of the diluted cell-free culture broth were added 100 µl of 1.5 × 
106 CFU/ml of indicator bacteria or yeast suspension and assigned 
as the experimental group. Well which had 100 µl of alone medium 
with 100 µl of 1.5 × 106
Minimum bactericidal concentration (MBC) or Minimum 
fungicidal concentration (MFC) assay 
 CFU/ml of indicator bacteria or yeast 
suspension was assigned as a control group. Both experimental and 
control groups were incubated at 37 °C for 24 h for indicator 
bacteria and 30 °C for 48 h for yeast in static incubator. The well 
with the least concentration of bioactive compounds showing no 
growth was taken as the MIC value for the respective 
microorganism. 
The MBC or MFC value was determined by using subculture 
technique [11]. Briefly, 100 µl of each indicator microorganism cell 
suspension of well that showed MIC value and 3 wells with greater 
than the MIC value were spread on fresh MH or SD agar medium 
without antibiotic and incubated at 37 °C for 24 h for indicator 
bacteria or 30 °C for 48 h for yeast in static incubator. After 
incubation, if the growth of indicator bacteria and yeast were 
observed lower than 5 colonies, it indicated that the concentration of 
bioactive compounds of these well was MBC or MFC value. 
Cytotoxicity bioassay 
The cytotoxic activity of bioactive compounds was investigated by 
means of brine shrimp lethality bioassay [12]. In this method, the 
eggs of the brine shrimp, Artemia salina Leach, which kindly 
obtained from the faculty of Aquaculture Technology, School of 
Agricultural Technology, Walailak University, Nakhon Si Thammarat, 
Thailand, was hatched in artificial sea water (3.8 % NaCl solution) 
for 48 h to mature brine shrimp called nauplii (Larvae). Meanwhile, 
bioactive compounds were prepared by dissolving them into LB/2 
broth medium to attain 500 µl of series concentrations of 225.00, 
200.00, 175.00, 150.00, 127.00, 63.50, 31.75, 15.87, 7.94, 3.97, 1.98, 
0.99, 0.49 and 0.25 µg/ml. 500 µl of LB/2 broth medium without 
bioactive compounds was assigned as the control vial. Both 
experimental and control vials were added 500 µl of 7.6 % NaCl 
solution to attain the final NaCl concentration of 3.8 %. Then 10 
nauplii were applied to all experimental vials and control vial. The 
number of nauplii that died after 24 h was counted. The findings 
were graphically presented by plotting of bioactive compounds 
concentration versus percentage of mortality rate of nauplii from 
which LC 50
Statistical analysis 
 was determined by extrapolation. 
The obtained data were analyzed by using SPSS software version 17. 
One-way ANOVA (Analysis of Variance) was employed and the level 
of significance was P-value<0.05. Post-hoc turkey test was used to 
investigate the differences between the data. 
RESULTS AND DISCUSSION 
Selection and isolation of interesting isolate, KB1  
After LB medium plate which was used to collect microorganisms 
from the air sample at Ao-nang, Krabi province, Thailand, was 
incubated at 30 °C in static incubator for 7 d. The embed colony, 
showed fungal-like formation, was isolated as pure culture by using 
aseptic technique for Gram staining. The isolate colony showed 
Gram positive branching formation, known as actinomycetes and 
named as KB1. Actinomycetes are the largest number of 
environmental microorganisms such as air, soil, water, mangrove 
sediment etc. [13]. From extensive studies in the past three decades, 
actinomycetes have been proven themselves as reliable sources of 
novel bioactive compounds and richest source of secondary 
metabolites [14]. 
Antibacterial activity screening 
The isolate KB1 was preliminarily screened to produce the bioactive 
compounds and its antibacterial activity against indicator bacteria 
viz. B. cereus TISTR 11778, M. luteus TISTR 884, S. aureus TISTR 517, 
ESBL in a clinical isolate of E. coli, Ps. aeruginosa TISTR 1467 and S. 
typhimurium TISTR 292 by cross streak method. The cross-streaking 
is an easy and relatively rapid method for screening cultures in 
search for new antibiotics or bioactive compounds. This method, the 
isolate KB1 produced bioactive compounds and diffused into the 
agar around its swath. As a result, the inhibitory activity of the 
isolate KB1 could preliminarily screen against many indicator 
bacteria in one-time [8]. It was found that bioactive compounds, 
produced by the isolate KB1, showed a broad spectrum of 
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antibacterial activity against both representative of Gram-positive 
bacteria (B. cereus TISTR 11778 and S. aureus TISTR 517) and Gram-
negative bacteria (Ps. aeruginosa TISTR 1467 and S. typhimurium 
TISTR 292) but could not inhibit ESBL in a clinical isolate of E. coli. 
While, M. luteus TISTR 884 could not interpret results, because it is no 
grown both experimental and control plate (fig. 1). This finding indicated 
that the isolate KB1 could produce interesting bioactive compounds 
which might be develop as medicinal important agent in the future. 
Therefore, it was identified the genus and species in the later time. 
 
 
Fig. 1: Preliminary antibacterial activity screening of the isolate 
KB1was investigated by comparing the length of growth line of 
indicator bacteria, illustrated in representative plate (A), 
between experimental plate (B) and control plate (C) 
 
Phylogenetic analysis 
After 16S rDNA gene amplification, the resulted sequence 
(approximately 1,445 bp) was subjected to similarity searches 
against public databases to infer possible phylogenetic relationship 
of the isolate KB1. The phylogenetic tree, which illustrated in fig. 2, 
indicated that the isolate KB1 should be placed in the genus 
Streptomyces. In the comparison of 16S rDNA gene sequences, the 
isolate KB1 was mostly related to S. varsoviensis NRRL B-3589T 
(98.89%), S. youssoufiensis X4T (98.68%) and S. ramulosus NRRL B-
2714T (98.61%). While, Kitasatospora setae KM-6054T
Anti-S. aureus TISTR 517 activity and protein concentration of 
cell-free culture broth 
 was used as 
an out-group. Based on the morphology and molecular phylogeny, 
the isolate KB1 was identified as genus Streptomyces and named as 
Streptomyces sp. KB1. The 16S rDNA gene sequence of Streptomyces 
sp. KB1 has been deposited in the GenBank database under the 
accession number KF939581.1. 
Cell-free culture broth of each day was tested anti-S. aureus TISTR 
517 activity and measured the protein concentration by agar well 
diffusion method and Bradford assay, respectively. It was found that 
Streptomyces sp. KB1 could produce bioactive compounds within 2 d 
of cultivation. Whereas, the highest significant activity was shown 
since day 4th
This surprising result might correlate with a decrease of nutritional 
value from LB to LB/2. Nevertheless, anti-S. aureus TISTR 517 
activity of bioactive compounds that obtained from cultivating 
Streptomyces sp. KB1 both in LB and LB/2 broth medium did not 
differ significantly (P-value<0.05) (data not shown). These findings 
were supported by research of Monthon et al. Which reported that 
the best antimicrobial activity of Streptomyces lydicus A2 was seen 
by cultivating it in LB/2 broth medium and decrease in nutritional 
value from LB to LB/2 did not increase the number of inhibited test 
microorganism [16]. Moreover, this experiment also found that cell-
free culture broth showed positive results after it was tested by the 
ninhydrin reaction which was assayed for detecting of protein or 
peptide. From these observing indicated that cell-free culture broth 
had composed of protein or peptide. Therefore, cell-free culture 
broth has been measured protein concentration and defined the 
scale unit as µg of protein/ml. Commonly, bioactive compounds 
which produced by genus Streptomyces had two major groups 
include (i) polyketide and (ii) polypeptide compounds [6]. The most 
were reported as polyketide compound [17]. Whereas in this study, 
it is possible that bioactive compounds might be as polypeptide 
compound similar to polypeptide antibiotic that produced by 
Streptomyces parvulus [18].  
 of incubation period, which had the protein 
concentration equal 254 ± 3.1 µg/ml (P-value<0.05) (table 1). This 
experiment was performed to evaluate the best incubation period 
for bioactive compounds production and design the scale unit of 
them for interpreting results as quantitativeness. Surprisingly, it was 
found that Streptomyces sp. KB1 could fast produce bioactive 
compounds more than other Streptomyces which the most were in 
the range of 7-14 d of cultivation [15].  
 
Table 1: Zone of inhibition and protein concentration of cell-free culture broth of each day 
Incubation period (days) Zone of inhibition (mm) Protein concentration (µg/ml)* * 
1 0.00 ± 0.0  17 ± 2.2  
2 20.33 ± 0.6 102 ± 6.3 
3 21.67 ± 0.6  164 ± 6.7 
4 23.67 ± 0.6  254 ± 3.1 
5 23.67 ± 0.6 252 ± 8.7 
6 23.67 ± 0.6 252 ± 1.0 
7 23.33 ± 0.6 250 ± 3.9 
*
 
 The data obtained from three triplicates and represented as mean ± SD. 
Biological activities of bioactive compounds 
Bioactive compounds were diluted as 2-fold serial dilution (0.25-
127.00 µg/ml) for using in broth micro dilution method and 
prepared at different concentration levels from 0.25 to 225.00 µg/ml 
for using in brine shrimp lethality bioassay. In this experiment found 
that both MIC and MBC values of bioactive compounds against the 
representative of Gram-positive bacteria were in the range 0.49-0.99 
µg/ml. For the representative of Gram-negative bacteria, MIC and 
MBC values of bioactive compounds were in the range 1.98-63.50 
and 3.97-127 µg/ml, respectively. While, MIC and MFC values of 
bioactive compounds against yeasts were in the range 15.87-31.75 
and equal to 63.50 µg/ml, respectively (table 2). From these finding 
indicated that bioactive compounds showed strongly inhibitory 
efficiency against Gram-positive bacteria, moderately inhibitory 
efficiency against Gram-negative bacteria and weakly inhibitory 
efficiency against yeasts including Ps. aeruginosa TISTR 1467 (P-
value<0.05).  
However, this result also indicated that bioactive compounds 
showed bactericidal or fungicidal activity against all indicator 
microorganisms which considered from MBC or MFC/MIC value of 
each indicator microorganism lower than or equal 4 (≤ 4). Brine 
shrimp lethality bioassay, the effect of the bioactive compounds on 
the mortality rate of nauplii showed a concentration dependent 
activity (table 3). Protein concentration of bioactive compounds 
versus percentage of mortality rate of nauplii was plotted as a linear 
correlation graph. From this, a linear correlation graph could 
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interpret 50 % lethal concentration (LC50) equal 131.58 µg/ml (fig. 
3). When considering the LC50
 
 value found that it was significantly 
higher than both MIC and MBC or MFC value (P-value<0.05). 
Therefore, this experiment demonstrated that bioactive compounds 
in cell-free culture broth had a weak cytotoxic activity against brine 
shrimp nauplii and also might be including to normal cells. 
 
Fig. 2: The phylogram showing the position of the isolate KB1 with other Streptomyces based on 16S rDNA gene. Phylogenetic tree based 
on a neighbor-joining analysis of 1,000 resembled data. Number of nodes indicates the percent level of bootstrap support. The scale bar 
represents 0.005 substitutions per nucleotide position 
 
Table 2: MIC and MBC or MFC values of bioactive compounds against each indicator microorganism 
Indicator microorganisms MIC* MBC or MFC value (µg/ml) * value (µg/ml) 
Gram-positive bacteria    
 B. cereus TISTR 11778 0.49 0.49 
 M. luteus TISTR 884 0.49 0.49 
 S. aureus TISTR 517 0.99 0.99 
Gram-negative bacteria   
 E. coli TISTR 887 3.97 7.94 
 Ps. aeruginosa TISTR 1467 63.50 127.00 
 S. typhimurium TISTR 292 1.98 3.97 
Yeasts   
 C. albicans 15.87 63.50 
 C. neoformans 31.75 63.50 
*
 
 The data obtained from three triplicates and represented as the median. 
Table 3: Percentage of the mortality rate of nauplii after exposing with bioactive compounds at different concentration levels for 24 h and 
LC50
Protein concentration of bioactive compounds 
(µg/ml) 
 value of bioactive compounds on nauplii 
The mortality rate of nauplii after exposed with 





 value  















* The data obtained from three triplicates and represented as the average.  
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Fig. 3: Linear correlations between protein concentrations of 
bioactive compounds versus percentage of mortality rate of nauplii 
 
CONCLUSION 
The isolate described in this study was identified as novel species of 
genus Streptomyces and has been published in the Gen Bank database 
under the accession number KF939581.1. Small-scale liquid 
cultivation, LB/2 broth medium was used to produce bioactive 
compounds from this isolate. Bioactive compounds in cell-free culture 
broth which had a protein concentration of 254 ± 3.1 µg/ml showed 
MIC and MBC or MFC values on each indicator microorganism at 
different concentration levels in the range 0.49-63.50 and 0.49-127.00 
µg/ml, respectively. When considering the LCR50R value of bioactive 
compounds on nauplii which equaled 131.58 µg/ml found that it is 
significantly higher than both MIC and MBC or MFC values (P-
value<0.05). This result demonstrated that these bioactive compounds 
have been interested and also might be as important polypeptide 
compound(s) that can be used as lead compound for development of 
novel polypeptide antibiotic in the future. Therefore, future our works 
will increase the yield of these bioactive compounds and then extract, 
purify and analyze the chemical structure of pure active compound 
including confirm the cytotoxicity in in vivo experiments.  
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